In conclusion, our study demonstrates that the novel anti-HER2 humanized antibody HuA21 exerts anti-tumor activity in vitro and in vivo via enhanced antibody internalization and the inhibition of the HER-related ERK1/2 and Akt pathways. The gene discussed is AKT1; the disease is neoplasm.